Cargando…

Novel lanthanide-labeled metal oxide nanoparticles improve the measurement of in vivo clearance and translocation

The deposition, clearance and translocation of europium-doped gadolinium oxide nanoparticles in a mouse lung were investigated experimentally. Nanoparticles were synthesized by spray flame pyrolysis. The particle size, crystallinity and surface properties were characterized. Following instillation,...

Descripción completa

Detalles Bibliográficos
Autores principales: Abid, Aamir D, Anderson, Donald S, Das, Gautom K, Van Winkle, Laura S, Kennedy, Ian M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560106/
https://www.ncbi.nlm.nih.gov/pubmed/23305071
http://dx.doi.org/10.1186/1743-8977-10-1
_version_ 1782257733099061248
author Abid, Aamir D
Anderson, Donald S
Das, Gautom K
Van Winkle, Laura S
Kennedy, Ian M
author_facet Abid, Aamir D
Anderson, Donald S
Das, Gautom K
Van Winkle, Laura S
Kennedy, Ian M
author_sort Abid, Aamir D
collection PubMed
description The deposition, clearance and translocation of europium-doped gadolinium oxide nanoparticles in a mouse lung were investigated experimentally. Nanoparticles were synthesized by spray flame pyrolysis. The particle size, crystallinity and surface properties were characterized. Following instillation, the concentrations of particles in organs were determined with inductively coupled plasma mass spectrometry. The protein corona coating the nanoparticles was found to be similar to the coating on more environmentally relevant nanoparticles such as iron oxide. Measurements of the solubility of the nanoparticles in surrogates of biological fluids indicated very little propensity for dissolution, and the elemental ratio of particle constituents did not change, adding further support to the contention that intact nanoparticles were measured. The particles were intratracheally instilled into the mouse lung. After 24 hours, the target organs were harvested, acid digested and the nanoparticle mass in each organ was measured by inductively coupled plasma mass spectrometry (ICP-MS). The nanoparticles were detected in all the studied organs at low ppb levels; 59% of the particles remained in the lung. A significant amount of particles was also detected in the feces, suggesting fast clearance mechanisms. The nanoparticle system used in this work is highly suitable for quantitatively determining deposition, transport and clearance of nanoparticles from the lung, providing a quantified measure of delivered dose.
format Online
Article
Text
id pubmed-3560106
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35601062013-02-04 Novel lanthanide-labeled metal oxide nanoparticles improve the measurement of in vivo clearance and translocation Abid, Aamir D Anderson, Donald S Das, Gautom K Van Winkle, Laura S Kennedy, Ian M Part Fibre Toxicol Research The deposition, clearance and translocation of europium-doped gadolinium oxide nanoparticles in a mouse lung were investigated experimentally. Nanoparticles were synthesized by spray flame pyrolysis. The particle size, crystallinity and surface properties were characterized. Following instillation, the concentrations of particles in organs were determined with inductively coupled plasma mass spectrometry. The protein corona coating the nanoparticles was found to be similar to the coating on more environmentally relevant nanoparticles such as iron oxide. Measurements of the solubility of the nanoparticles in surrogates of biological fluids indicated very little propensity for dissolution, and the elemental ratio of particle constituents did not change, adding further support to the contention that intact nanoparticles were measured. The particles were intratracheally instilled into the mouse lung. After 24 hours, the target organs were harvested, acid digested and the nanoparticle mass in each organ was measured by inductively coupled plasma mass spectrometry (ICP-MS). The nanoparticles were detected in all the studied organs at low ppb levels; 59% of the particles remained in the lung. A significant amount of particles was also detected in the feces, suggesting fast clearance mechanisms. The nanoparticle system used in this work is highly suitable for quantitatively determining deposition, transport and clearance of nanoparticles from the lung, providing a quantified measure of delivered dose. BioMed Central 2013-01-10 /pmc/articles/PMC3560106/ /pubmed/23305071 http://dx.doi.org/10.1186/1743-8977-10-1 Text en Copyright ©2013 Abid et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Abid, Aamir D
Anderson, Donald S
Das, Gautom K
Van Winkle, Laura S
Kennedy, Ian M
Novel lanthanide-labeled metal oxide nanoparticles improve the measurement of in vivo clearance and translocation
title Novel lanthanide-labeled metal oxide nanoparticles improve the measurement of in vivo clearance and translocation
title_full Novel lanthanide-labeled metal oxide nanoparticles improve the measurement of in vivo clearance and translocation
title_fullStr Novel lanthanide-labeled metal oxide nanoparticles improve the measurement of in vivo clearance and translocation
title_full_unstemmed Novel lanthanide-labeled metal oxide nanoparticles improve the measurement of in vivo clearance and translocation
title_short Novel lanthanide-labeled metal oxide nanoparticles improve the measurement of in vivo clearance and translocation
title_sort novel lanthanide-labeled metal oxide nanoparticles improve the measurement of in vivo clearance and translocation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560106/
https://www.ncbi.nlm.nih.gov/pubmed/23305071
http://dx.doi.org/10.1186/1743-8977-10-1
work_keys_str_mv AT abidaamird novellanthanidelabeledmetaloxidenanoparticlesimprovethemeasurementofinvivoclearanceandtranslocation
AT andersondonalds novellanthanidelabeledmetaloxidenanoparticlesimprovethemeasurementofinvivoclearanceandtranslocation
AT dasgautomk novellanthanidelabeledmetaloxidenanoparticlesimprovethemeasurementofinvivoclearanceandtranslocation
AT vanwinklelauras novellanthanidelabeledmetaloxidenanoparticlesimprovethemeasurementofinvivoclearanceandtranslocation
AT kennedyianm novellanthanidelabeledmetaloxidenanoparticlesimprovethemeasurementofinvivoclearanceandtranslocation